MayMM personal page - To The Moon

MayMM

MayMM

No personal profile

2Follow

2Followers

0Topic

0Badge

2023-05-06

$Olam Group(VC2.SI)$ anyone received the dividend yet?

2021-08-30

$OLAM INTERNATIONAL LIMITED(O32.SI)$Where to check the dividend distribution? Today right?

2021-07-22

$OLAM INTERNATIONAL LIMITED(O32.SI)$Suddenly became US stocks [Spurting]

2021-07-05

I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. if it’sgoing down and down, right shares also cannot help much

@Jellybeanz:$OLAM INTERNATIONAL LIMITED(O32.SI)$sad

2021-06-22

$OLAM INTERNATIONAL LIMITED(O32.SI)$What happened? Why suddenly drop so much

2021-06-18

That’s another shitty news to start the day

Orphazyme shares tumbled more than 60% in pre-market trading

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582066406420230","uuid":"3582066406420230","gmtCreate":1618972527769,"gmtModify":1624006944347,"name":"MayMM","pinyin":"maymm","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":2,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.49%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9947400586,"gmtCreate":1683378584445,"gmtModify":1683378587187,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VC2.SI\">$Olam Group(VC2.SI)$&nbsp;</a>anyone received the dividend yet?","listText":"<a href=\"https://ttm.financial/S/VC2.SI\">$Olam Group(VC2.SI)$&nbsp;</a>anyone received the dividend yet?","text":"$Olam Group(VC2.SI)$ anyone received the dividend yet?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9947400586","isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3557880070444625","authorId":"3557880070444625","name":"Sporeshare","avatar":"https://static.tigerbbs.com/b834a9afafa96ec1133650e853d8e74f","crmLevel":6,"crmLevelSwitch":1,"idStr":"3557880070444625","authorIdStr":"3557880070444625"},"content":"pay date 10 May.","text":"pay date 10 May.","html":"pay date 10 May."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811159543,"gmtCreate":1630300496582,"gmtModify":1676530261838,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Where to check the dividend distribution? Today right?","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Where to check the dividend distribution? Today right?","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$Where to check the dividend distribution? Today right?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811159543","isVote":1,"tweetType":1,"viewCount":805,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"content":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon","text":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon","html":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172197831,"gmtCreate":1626942730023,"gmtModify":1703481006710,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Suddenly became US stocks [Spurting]&nbsp;","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Suddenly became US stocks [Spurting]&nbsp;","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$Suddenly became US stocks [Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172197831","isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154007556,"gmtCreate":1625458335275,"gmtModify":1703742110506,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. &nbsp;if it’sgoing down and down, right shares also cannot help much","listText":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. &nbsp;if it’sgoing down and down, right shares also cannot help much","text":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. if it’sgoing down and down, right shares also cannot help much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154007556","repostId":"155439820","repostType":1,"repost":{"id":155439820,"gmtCreate":1625448043960,"gmtModify":1703741839696,"author":{"id":"3577744404108100","authorId":"3577744404108100","name":"Jellybeanz","avatar":"https://community-static.tradeup.com/news/183b35b93a7d70a3b175f2b47a5af404","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577744404108100","authorIdStr":"3577744404108100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>sad","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>sad","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$sad","images":[{"img":"https://static.tigerbbs.com/179b7b7e7e05d8a4a2c46ed46d1390c3","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155439820","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120433279,"gmtCreate":1624331161991,"gmtModify":1703833710172,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>What happened? Why suddenly drop so much","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>What happened? Why suddenly drop so much","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$What happened? Why suddenly drop so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120433279","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577744404108100","authorId":"3577744404108100","name":"Jellybeanz","avatar":"https://community-static.tradeup.com/news/183b35b93a7d70a3b175f2b47a5af404","crmLevel":4,"crmLevelSwitch":0,"idStr":"3577744404108100","authorIdStr":"3577744404108100"},"content":"rights issue looooooo","text":"rights issue looooooo","html":"rights issue looooooo"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166849765,"gmtCreate":1624003847857,"gmtModify":1703826285464,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"That’s another shitty news to start the day","listText":"That’s another shitty news to start the day","text":"That’s another shitty news to start the day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166849765","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9947400586,"gmtCreate":1683378584445,"gmtModify":1683378587187,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VC2.SI\">$Olam Group(VC2.SI)$&nbsp;</a>anyone received the dividend yet?","listText":"<a href=\"https://ttm.financial/S/VC2.SI\">$Olam Group(VC2.SI)$&nbsp;</a>anyone received the dividend yet?","text":"$Olam Group(VC2.SI)$ anyone received the dividend yet?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9947400586","isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3557880070444625","authorId":"3557880070444625","name":"Sporeshare","avatar":"https://static.tigerbbs.com/b834a9afafa96ec1133650e853d8e74f","crmLevel":6,"crmLevelSwitch":1,"idStr":"3557880070444625","authorIdStr":"3557880070444625"},"content":"pay date 10 May.","text":"pay date 10 May.","html":"pay date 10 May."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811159543,"gmtCreate":1630300496582,"gmtModify":1676530261838,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Where to check the dividend distribution? Today right?","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Where to check the dividend distribution? Today right?","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$Where to check the dividend distribution? Today right?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811159543","isVote":1,"tweetType":1,"viewCount":805,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"content":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon","text":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon","html":"Actually can check at the trade page , The stock name row, scroll to right, beside the close eye icon"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120433279,"gmtCreate":1624331161991,"gmtModify":1703833710172,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>What happened? Why suddenly drop so much","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>What happened? Why suddenly drop so much","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$What happened? Why suddenly drop so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120433279","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577744404108100","authorId":"3577744404108100","name":"Jellybeanz","avatar":"https://community-static.tradeup.com/news/183b35b93a7d70a3b175f2b47a5af404","crmLevel":4,"crmLevelSwitch":0,"idStr":"3577744404108100","authorIdStr":"3577744404108100"},"content":"rights issue looooooo","text":"rights issue looooooo","html":"rights issue looooooo"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172197831,"gmtCreate":1626942730023,"gmtModify":1703481006710,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Suddenly became US stocks [Spurting]&nbsp;","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Suddenly became US stocks [Spurting]&nbsp;","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$Suddenly became US stocks [Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172197831","isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154007556,"gmtCreate":1625458335275,"gmtModify":1703742110506,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. &nbsp;if it’sgoing down and down, right shares also cannot help much","listText":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. &nbsp;if it’sgoing down and down, right shares also cannot help much","text":"I’m worse. Cost price $1.75. What’s happening.. within a month from $1.8 to $1.5.. if it’sgoing down and down, right shares also cannot help much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154007556","repostId":"155439820","repostType":1,"repost":{"id":155439820,"gmtCreate":1625448043960,"gmtModify":1703741839696,"author":{"id":"3577744404108100","authorId":"3577744404108100","name":"Jellybeanz","avatar":"https://community-static.tradeup.com/news/183b35b93a7d70a3b175f2b47a5af404","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577744404108100","authorIdStr":"3577744404108100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>sad","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>sad","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$sad","images":[{"img":"https://static.tigerbbs.com/179b7b7e7e05d8a4a2c46ed46d1390c3","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155439820","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166849765,"gmtCreate":1624003847857,"gmtModify":1703826285464,"author":{"id":"3582066406420230","authorId":"3582066406420230","name":"MayMM","avatar":"https://static.tigerbbs.com/8b92af3e29db0cc811ba81eb0045074c","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582066406420230","authorIdStr":"3582066406420230"},"themes":[],"htmlText":"That’s another shitty news to start the day","listText":"That’s another shitty news to start the day","text":"That’s another shitty news to start the day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166849765","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}